Skip to main content

Advertisement

SpringerLink
Log in

Pediatric Nausea—a Review of Current Management

  • Pediatric Gastroenterology (SA Saeed and E Mezoff, Section Editors)
  • Published:
Current Treatment Options in Pediatrics Aims and scope Submit manuscript

Abstract

Purpose of Review

Nausea is a common symptom in children for a variety of reasons ranging from intestinal, extraintestinal, and functional. Defining it is challenging as some children may not be able to verbalize the symptoms and it is often associated with functional gastrointestinal disorders (FGIDs). The burden of nausea amongst children has been demonstrated by its association with anxiety, depression, and impaired school performance. This review will discuss the pathophysiology of childhood nausea along with established and new treatment options.

Recent Findings

By exploring the biopsychosocial model, namely the interplay between peripheral chemoreceptors, central neuronal pathways, and the environment, we can improve diagnosis and management. The diagnosis of nausea is mainly clinical and it is important to identify alarm symptoms, such as weight loss, bilious emesis, and neurologic symptoms, that would prompt further evaluation. There are numerous causes of nausea to consider, including both intestinal and extraintestinal pathologies. A detailed history and physical exam frequently help to narrow the diagnosis. The treatment options for nausea are expanding and include pharmacologic and non-pharmacologic therapies, but further research is imperative.

Summary

This review focuses on the current treatment opinions in the management of pediatric nausea based on the biopsychosocial model and focuses on newer therapies and includes non-pharmacological approaches to childhood nausea.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Hasler WL, Chey WD. Nausea and vomiting. Gastroenterology. 2003;125(6):1860–7.

    Article  Google Scholar 

  2. Saps M. High prevalence of nausea among school children in Latin America. J Pediatr. 2016;169:98–104.

    Article  Google Scholar 

  3. Kovacic K, et al. High prevalence of nausea in children with pain-associated functional gastrointestinal disorders: are Rome criteria applicable? J Pediatr Gastroenterol Nutr. 2013;57(3):311–5.

    Article  Google Scholar 

  4. Chitkara DK, Rawat DJ, Talley NJ. The epidemiology of childhood recurrent abdominal pain in Western countries: a systematic review. Am J Gastroenterol. 2005;100(8):1868–75.

    Article  Google Scholar 

  5. Russell A, Sherman AL, Walker LS. 620 nausea complicating recurrent abdominal pain in childhood predicts functional GI disorders, disability, depression and anxiety in young adulthood: results of a prospective cohort study. Gastroenterology. 2015;148(4):S-122.

    Article  Google Scholar 

  6. Hornby PJ. Central neurocircuitry associated with emesis. Am J Med. 2001;111 Suppl 8A(8):106S-112S.

    Article  CAS  Google Scholar 

  7. Kovacic K, Di Lorenzo C. Functional nausea in children. J Pediatr Gastroenterol Nutr. 2016;62(3):365–71.

    Article  Google Scholar 

  8. Kashyap P, Farrugia G. Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years. Gut. 2010;59(12):1716.

    Article  CAS  Google Scholar 

  9. Pasricha PJ, et al. Characteristics of patients with chronic unexplained nausea and vomiting and normal gastric emptying. Clin Gastroenterol Hepatol. 2011;9(7):567-76.e1-4.

    Article  Google Scholar 

  10. Chelimsky G, et al. Autonomic abnormalities in children with functional abdominal pain: coincidence or etiology? J Pediatr Gastroenterol Nutr. 2001;33(1):47–53.

    Article  CAS  Google Scholar 

  11. Lacount L, et al. Dynamic cardiovagal response to motion sickness: a point-process heart rate variability study. Comput Cardiol. 2009;36:49–52.

    Google Scholar 

  12. Kim YY, et al. Characteristic changes in the physiological components of cybersickness. Psychophysiology. 2005;42(5):616–25.

    Google Scholar 

  13. Koppen IJN, et al. The pediatric Rome IV criteria: what’s new? Expert Rev Gastroenterol Hepatol. 2017;11(3):1–9.

    Article  Google Scholar 

  14. Gershon MD. 5-Hydroxytryptamine (serotonin) in the gastrointestinal tract. Curr Opin Endocrinol Diabetes Obes. 2013;20(1):14–21.

    Article  CAS  Google Scholar 

  15. Lummis SCR. 5-HT3 receptors*. J Biol Chem. 2012;287(48):40239–45.

    Article  CAS  Google Scholar 

  16. Galligan JJ. Ligand-gated ion channels in the enteric nervous system. Neurogastroenterol Motil. 2002;14(6):611–23.

    Article  CAS  Google Scholar 

  17. Loewen PS, Marra CA, Zed PJ. 5-HT3 receptor antagonistsvs traditional agents for the prophylaxis of postoperative nausea and vomiting. Can J Anesth. 2000;47(10):1008–18.

    Article  CAS  Google Scholar 

  18. Niño-Serna LF, Acosta-Reyes J, Veroniki A-A, Florez ID. Antiemetics in children with acute gastroenteritis: a meta-analysis. Pediatrics. 2020;145(4). https://doi.org/10.1542/peds.2019-3260

  19. Kovacic K, et al. Chronic idiopathic nausea of childhood. J Pediatr. 2014;164(5):1104–9.

    Article  Google Scholar 

  20. Belkacemi L, Darmani NA. Dopamine receptors in emesis: molecular mechanisms and potential therapeutic function. Pharmacol Res. 2020;161:105124.

    Article  CAS  Google Scholar 

  21. Sanger GJ, Broad J, Andrews PLR. The relationship between gastric motility and nausea: gastric prokinetic agents as treatments. Eur J Pharmacol. 2013;715(1–3):10–4.

    Article  CAS  Google Scholar 

  22. Freedman SB, Fuchs S. Antiemetic therapy in pediatric emergency departments. Pediatr Emerg Care. 2004;20(9):625–33 (quiz 633-5).

    Article  Google Scholar 

  23. Lau Moon Lin M, et al. The safety of metoclopramide in children: a systematic review and meta-analysis. Drug Saf. 2016;39(7):675–87.

    Article  Google Scholar 

  24. Cristofori F, et al. Efficacy of the neurokinin-1 receptor antagonist aprepitant in children with cyclical vomiting syndrome. Aliment Pharmacol Ther. 2014;40(3):309–17.

    Article  CAS  Google Scholar 

  25. Fahler J, Wall GC, Leman BI. Gastroparesis-associated refractory nausea treated with aprepitant. Ann Pharmacother. 2012;46(12):e38.

    Article  Google Scholar 

  26. Gupta K, Walton R, Kataria SP. Chemotherapy-induced nausea and vomiting: pathogenesis, recommendations, and new trends. Cancer Treat Res Commun. 2021;26:100278.

    Article  Google Scholar 

  27. Cangemi DJ, Kuo B. Practical perspectives in the treatment of nausea and vomiting. J Clin Gastroenterol. 2019;53(3):170–8. This article distinguishes between the pathophysiologies of acute and chronic nausea. It provides a comprehensive overview of the management of chronic nausea and vomiting, mainly in adults. There is a concise summary of the mechanisms, dosage, and side effects of current therapies used for nausea and vomiting.

    Article  Google Scholar 

  28. • Arruda J, Yeh AM. Integrative approach to pediatric nausea. Pediatr Ann. 2019;48(6):e236–42. This article is one of few that outlines the emerging nonpharmacologic therapies for the management of pediatric nausea including mind-body modalities, botanicals and supplements, acupuncture, and aromatherapy. Each therapy is discussed along with a review of the study population, strength of evidence, side effects, and recommendations.

    Article  Google Scholar 

  29. Kovacic K, Sood M, Venkatesan T. Cyclic vomiting syndrome in children and adults: what is new in 2018? Curr Gastroenterol Rep. 2018;20(10):46.

    Article  Google Scholar 

  30. Viljoen E, et al. A systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting. Nutr J. 2014;13(20):20.

    Article  Google Scholar 

  31. Ernst E, Pittler MH. Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. Br J Anaesth. 2000;84(3):367–71.

    Article  CAS  Google Scholar 

  32. Bossi P, et al. A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin. Ann Oncol. 2017;28(10):2547–51.

    Article  CAS  Google Scholar 

  33. Crichton M, et al. Efficacy of ginger (Zingiber officinale) in ameliorating chemotherapy-induced nausea and vomiting and chemotherapy-related outcomes: a systematic review update and meta-analysis. J Acad Nutr Diet. 2019;119(12):2055–68.

    Article  Google Scholar 

  34. Kline RM, et al. Enteric-coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. J Pediatr. 2001;138(1):125–8.

    Article  CAS  Google Scholar 

  35. Chumpitazi BP, Kearns GL, Shulman RJ. Review article: the physiological effects and safety of peppermint oil and its efficacy in irritable bowel syndrome and other functional disorders. Aliment Pharmacol Ther. 2018;47(6):738–52.

    Article  CAS  Google Scholar 

  36. Mapp CP, et al. Peppermint oil: evaluating efficacy on nausea in patients receiving chemotherapy in the ambulatory setting. Clin J Oncol Nurs. 2020;24(2):160–4.

    Article  Google Scholar 

  37. McParlin C, et al. Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review. JAMA. 2016;316(13):1392–401.

    Article  Google Scholar 

  38. von Arnim U, et al. STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study. Am J Gastroenterol. 2007;102(6):1268–75.

    Article  Google Scholar 

  39. Ottillinger B, et al. STW 5 (Iberogast®)—a safe and effective standard in the treatment of functional gastrointestinal disorders. Wiener Med Wochenschr (1946). 2013;163(3–4):65–72.

    Article  Google Scholar 

  40. Morehead A, Salmon G. Efficacy of acupuncture/acupressure in the prevention and treatment of nausea and vomiting across multiple patient populations. Nurs Clin N Am. 2020;55:571–80.

    Article  Google Scholar 

  41. Lee A, Chan SK, Fan LT. Stimulation of the wrist acupuncture point PC6 for preventing postoperative nausea and vomiting. Cochrane Database Syst Rev. 2015;2016(11):CD003281.

    Google Scholar 

  42. Richardson J, et al. Hypnosis for nausea and vomiting in cancer chemotherapy: a systematic review of the research evidence. Eur J Cancer Care (Engl). 2007;16(5):402–12.

    Article  CAS  Google Scholar 

  43. Haug TT, Mykletun A, Dahl AA. The prevalence of nausea in the community: psychological, social and somatic factors. Gen Hosp Psychiatry. 2002;24(2):81–6.

    Article  Google Scholar 

  44. Palsson OS, Ballou S. Hypnosis and cognitive behavioral therapies for the management of gastrointestinal disorders. Curr Gastroenterol Rep. 2020;22(7):31.

    Article  Google Scholar 

  45. Lembo A, et al. Relamorelin reduces vomiting frequency and severity and accelerates gastric emptying in adults with diabetic gastroparesis. Gastroenterology. 2016;151(1):87-96.e6.

    Article  CAS  Google Scholar 

  46. Parkman HP, Carlson MR, Gonyer D. Metoclopramide nasal spray is effective in symptoms of gastroparesis in diabetics compared to conventional oral tablet. Neurogastroenterol Motil. 2014;26(4):521–8.

    Article  CAS  Google Scholar 

  47. Teich S, et al. Efficacy of permanent gastric electrical stimulation for the treatment of gastroparesis and functional dyspepsia in children and adolescents. J Pediatr Surg. 2013;48(1):178–83.

    Article  Google Scholar 

  48. Lu PL, Di Lorenzo C. Neurostimulation of the gastrointestinal tract in children: is it time to shock the gut? Curr Opin Pediatr. 2016;28(5):631–7.

    Article  CAS  Google Scholar 

  49. Babygirija R, et al. Percutaneous electrical nerve field stimulation modulates central pain pathways and attenuates post-inflammatory visceral and somatic hyperalgesia in rats. Neuroscience. 2017;356:11–21.

    Article  CAS  Google Scholar 

  50. • Krasaelap A, et al. Efficacy of auricular neurostimulation in adolescents with irritable bowel syndrome in a randomized, double-blind trial. Clin Gastroenterol Hepatol. 2020;18(9):1987-1994.e2. This randomized controlled trial assessed the impact of auricular neurostimulation on the severity of abdominal pain amongst patients with irritable bowel syndrome. The results demonstrated a significant improvement in abdominal pain severity among patients who received percutaneous electrical nerve field stimulation to the external ear as compared with those who received sham stimulation. This was a promising outcome for FGIDs, prompting a subsequent, pending trial in children with cyclic vomiting syndrome.

    Article  Google Scholar 

  51. Kovacic K, et al. Neurostimulation for abdominal pain-related functional gastrointestinal disorders in adolescents: a randomised, double-blind, sham-controlled trial. Lancet Gastroenterol Hepatol. 2017;2(10):727–37.

    Article  Google Scholar 

  52. Kovacic K. Efficacy of auricular neurostimulation for children and adults with cyclic vomiting syndrome: a pilot study. 2022. https://clinicaltrials.gov/ct2/show/NCT03434652.

Download references

Author information

Authors and Affiliations

  1. Pediatric Gastroenterology, University of Texas Southwestern, 5323 Harry Hines Blvd, Dallas, TX, 75390, USA

    Liane Sadder MD & Rinarani Sanghavi MD, MBA

Authors
  1. Liane Sadder MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rinarani Sanghavi MD, MBA
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rinarani Sanghavi MD, MBA.

Ethics declarations

Conflict of Interest

Liane Sadder declares that she has no conflict of interest. Rinarani Sanghavi declares that she has no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Pediatric Gastroenterology

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sadder, L., Sanghavi, R. Pediatric Nausea—a Review of Current Management. Curr Treat Options Peds 8, 354–368 (2022). https://doi.org/10.1007/s40746-022-00254-x

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40746-022-00254-x

Keywords

Search

Navigation